Cardiac fibrosis in the ageing heart: Contributors and mechanisms
MetadataShow full item record
© 2017 John Wiley & Sons Australia, Ltd. Cardiac fibrosis refers to an excessive deposition of extracellular matrix (ECM) in cardiac tissue. Fibrotic tissue is stiffer and less compliant, resulting in subsequent cardiac dysfunction and heart failure. Cardiac fibrosis in the ageing heart may involve activation of fibrogenic signalling and inhibition of anti-fibrotic signalling, leading to an imbalance of ECM turnover. Excessive accumulation of ECM such as collagen in older patients contributes to progressive ventricular dysfunction. Overexpression of collagen is derived from various sources, including higher levels of fibrogenic growth factors, proliferation of fibroblasts and cellular transdifferentiation. These may be triggered by factors, such as oxidative stress, inflammation, hypertension, cellular senescence and cell death, contributing to age-related fibrotic cardiac remodelling. In this review, we will discuss the fibrogenic contributors in age-related cardiac fibrosis, and the potential mechanisms by which fibrogenic processes can be interrupted for therapeutic intent.
Showing items related by title, author, creator and subject.
Late Gadolinium Enhancement Amount as an Independent Risk Factor for the Incidence of Adverse Cardiovascular Events in Patients with Stage C or D Heart FailureLiu, T.; Ma, X.; Liu, W.; Ling, S.; Zhao, L.; Xu, L.; Song, D.; Liu, J.; Sun, Zhonghua; Fan, Z.; Luo, T.; Kang, J.; Liu, X.; Dong, J. (2016)Background: Myocardial fibrosis (MF) is a risk factor for poor prognosis in dilated cardiomyopathy (DCM). Late gadolinium enhancement (LGE) of the myocardium on cardiac magnetic resonance (CMR) represents MF. We examined ...
Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE studyAshton, E.; Windebank, E.; Skiba, M.; Reid, Christopher; Schneider, H.; Rosenfeldt, F.; Tonkin, A.; Krum, H. (2011)Background: Statins are often prescribed for prevention of atherosclerotic outcomes in patients who have chronic heart failure (CHF), if this has an ischaemic etiology. These agents may also possess additional properties, ...
Image analysis algorithms for immunohistochemical assessment of cell death events and fibrosis in tissue sectionsKrajewska, M.; Smith, L.; Rong, J.; Huang, X.; Hyer, M.; Zeps, Nikolajs; Iacopetta, B.; Linke, S.; Olson, A.; Reed, J.; Krajewski, S. (2009)Cell death is of broad physiological and pathological importance, making quantification of biochemical events associated with cell demise a high priority for experimental pathology. Fibrosis is a common consequence of ...